Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy DOI Creative Commons
Ajaz A. Bhat, Sabah Nisar, Selma Maacha

et al.

Molecular Cancer, Journal Year: 2021, Volume and Issue: 20(1)

Published: Jan. 4, 2021

Abstract Esophageal cancer (EC) is a disease often marked by aggressive growth and poor prognosis. Lack of targeted therapies, resistance to chemoradiation therapy, distant metastases among patients with advanced account for the high mortality rate. The tumor microenvironment (TME) contains several cell types, including fibroblasts, immune cells, adipocytes, stromal proteins, factors, which play significant role in supporting behavior cells. complex dynamic interactions secreted cytokines, chemokines, their receptors mediate chronic inflammation immunosuppressive TME favoring progression, metastasis, decreased response therapy. molecular changes are used as biological markers diagnosis, prognosis, treatment patients. This review highlighted novel insights into understanding functional impact deregulated cytokines chemokines imparting EC, stressing nature therapeutic consequences cytokine-chemokine network. We also discuss oncogenic potential contributing Epithelial-Mesenchymal Transition (EMT), angiogenesis, immunosuppression, metastatic niche, development. In addition, it discusses wide range intracellular signaling pathways that occur TME. Overall, this relatively unexplored field could provide crucial immunology encourage effective application modulatory therapy EC.

Language: Английский

Melanoma models for the next generation of therapies DOI Creative Commons
E. Elizabeth Patton, Kristen L. Mueller, David J. Adams

et al.

Cancer Cell, Journal Year: 2021, Volume and Issue: 39(5), P. 610 - 631

Published: Feb. 5, 2021

Language: Английский

Citations

161

The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy DOI Creative Commons
Hai‐Hao Han, Han-Min Wang, Paramesh Jangili

et al.

Chemical Society Reviews, Journal Year: 2023, Volume and Issue: 52(3), P. 879 - 920

Published: Jan. 1, 2023

This tutorial review provides a general overview for the design of prodrugs and activatable phototherapeutics which enables development improved therapies.

Language: Английский

Citations

157

Flavonoids in Cancer Metastasis DOI Open Access

Alena Líšková,

Lenka Koklesová, Marek Samec

et al.

Cancers, Journal Year: 2020, Volume and Issue: 12(6), P. 1498 - 1498

Published: June 8, 2020

Metastasis represents a serious complication in the treatment of cancer. Flavonoids are plant secondary metabolites exerting various health beneficiary effects. The effects flavonoids against cancer associated not only with early stages process, but also progression and spread into distant sites. showed potent anti-cancer models vitro vivo, mediated via regulation key signaling pathways involved migration invasion cells metastatic progression, including regulators epithelial-mesenchymal transition or regulatory molecules such as MMPs, uPA/uPAR, TGF-β other contributors complex process spread. Moreover, modulated expression genes improved inflammatory status, part development metastasis. documented clear potential to improve effectiveness conventional chemotherapeutic agents. Most importantly, represent environmentally-friendly cost-effective substances; moreover, wide spectrum different demonstrated safety minimal side during long-termed administration. In addition, bioavailability can be by their conjugation metal ions structural modifications radiation. conclusion, flavonoids, targeting all phases carcinogenesis should implemented clinical research order strengthen use future targeted prevention therapy high-risk individuals patients aggressive disease potential.

Language: Английский

Citations

153

Tumor biomarkers for diagnosis, prognosis and targeted therapy DOI Creative Commons
Yue Zhou, Lei Tao, Jiahao Qiu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: May 20, 2024

Abstract Tumor biomarkers, the substances which are produced by tumors or body’s responses to during tumorigenesis and progression, have been demonstrated possess critical encouraging value in screening early diagnosis, prognosis prediction, recurrence detection, therapeutic efficacy monitoring of cancers. Over past decades, continuous progress has made exploring discovering novel, sensitive, specific, accurate tumor significantly promoted personalized medicine improved outcomes cancer patients, especially advances molecular biology technologies developed for detection biomarkers. Herein, we summarize discovery development including history conventional innovative used biomarker classification biomarkers based on tissue origins, application clinical management. In particular, highlight recent advancements biomarker-based anticancer-targeted therapies emerging as breakthroughs promising strategies. We also discuss limitations challenges that need be addressed provide insights perspectives turn into opportunities this field. Collectively, multiple emphasized review may guidance precision medicine, broaden horizons future research directions, expedite patients according their rather than organs origin.

Language: Английский

Citations

148

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis DOI Creative Commons

Yao‐Hui Huang,

Kun Cai,

Pengpeng Xu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2021, Volume and Issue: 6(1)

Published: Jan. 11, 2021

Abstract Epigenetic alterations play an important role in tumor progression of diffuse large B-cell lymphoma (DLBCL). However, the biological relevance epigenetic gene mutations on microenvironment remains to be determined. The core set genes relating histone methylation ( KMT2D , KMT2C EZH2 ), acetylation CREBBP EP300 DNA TET2 and chromatin remodeling ARID1A ) were detected training cohort 316 patients by whole-genome/exome sequencing (WGS/WES) validation 303 with newly diagnosed DLBCL targeted sequencing. Their correlation peripheral blood immune cells clinical outcomes assessed. Underlying mechanisms investigated both vitro vivo. Among all 619 patients, somatic (19.5%) most frequently observed, followed (8.7%), (8.4%), (8.2%), (7.8%), (6.8%), (2.9%). them, / significantly associated decreased absolute lymphocyte-to-monocyte ratios, as well inferior progression-free overall survival. In B-lymphoma cells, mutation or knockdown inhibited H3K27 acetylation, downregulated FBXW7 expression, activated NOTCH pathway, downstream CCL2/CSF1 resulting tumor-associated macrophage polarization M2 phenotype cell proliferation. murine models, xenografted tumors bearing presented lower higher recruitment, more rapid growth than those wild-type control via FBXW7-NOTCH-CCL2/CSF1 axis. Our work thus contributed understanding aberrant regulation alternative mechanism DLBCL.

Language: Английский

Citations

146

Theranostic Fluorescent Probes DOI Creative Commons
Amit Sharma, Peter Verwilst, Mingle Li

et al.

Chemical Reviews, Journal Year: 2024, Volume and Issue: 124(5), P. 2699 - 2804

Published: Feb. 29, 2024

The ability to gain spatiotemporal information, and in some cases achieve control, the context of drug delivery makes theranostic fluorescent probes an attractive intensely investigated research topic. This interest is reflected steep rise publications on topic that have appeared over past decade. Theranostic probes, their various incarnations, generally comprise a fluorophore linked masked drug, which released as result certain stimuli, with both intrinsic extrinsic stimuli being reported. release then signaled by emergence signal. Importantly, use appropriate fluorophores has enabled not only this emerging fluorescence marker for but also provided modalities useful photodynamic, photothermal, sonodynamic therapeutic applications. In review we highlight recent work particular focus are activated tumor microenvironments. We summarize efforts develop other applications, such neurodegenerative diseases antibacterials. celebrates diversity designs reported date, from discrete small-molecule systems nanomaterials. Our aim provide insights into potential clinical impact still-emerging direction.

Language: Английский

Citations

132

Anticancer Activity of Propolis and Its Compounds DOI
Ewa Forma, Magdalena Bryś

Nutrients, Journal Year: 2021, Volume and Issue: 13(8), P. 2594 - 2594

Published: July 28, 2021

Propolis is a natural material that honey bees (Apis mellifera) produce from various botanical sources. The therapeutic activity of propolis, including antibacterial, antifungal, and anti-inflammatory effects, have been known since antiquity. Cancer one the major burdens disease worldwide, therefore, numerous studies are being conducted to develop new chemotherapeutic agents treatments for cancer. rich source biologically active compounds, which affect signaling pathways regulating crucial cellular processes. results latest research show propolis can inhibit proliferation, angiogenesis, metastasis cancer cells stimulate apoptosis. Moreover, it may influence tumor microenvironment multidrug resistance cancers. This review briefly summarizes molecular mechanisms anticancer its compounds highlights potential benefits reduce side effects chemotherapy radiotherapy.

Language: Английский

Citations

128

Multifunctional nanoparticle-mediated combining therapy for human diseases DOI Creative Commons
Xiaotong Li,

Xiuju Peng,

Makhloufi Zoulikha

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Jan. 1, 2024

Abstract Combining existing drug therapy is essential in developing new therapeutic agents disease prevention and treatment. In preclinical investigations, combined effect of certain known drugs has been well established treating extensive human diseases. Attributed to synergistic effects by targeting various pathways advantages, such as reduced administration dose, decreased toxicity, alleviated resistance, combinatorial treatment now being pursued delivering combat major clinical illnesses, cancer, atherosclerosis, pulmonary hypertension, myocarditis, rheumatoid arthritis, inflammatory bowel disease, metabolic disorders neurodegenerative Combinatorial involves combining or co-delivering two more for a specific disease. Nanoparticle (NP)-mediated delivery systems, i.e., liposomal NPs, polymeric NPs nanocrystals, are great interest wide range due targeted delivery, extended release, higher stability avoid rapid clearance at infected areas. This review summarizes targets diseases, clinically approved combinations the development multifunctional emphasizes strategies based on severe Ultimately, we discuss challenging NP-codelivery translation provide potential approaches address limitations. offers comprehensive overview recent cutting-edge NP-mediated combination

Language: Английский

Citations

125

Anticancer Activity of Natural and Synthetic Chalcones DOI Open Access
Teodora Constantinescu, Claudiu N. Lungu

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(21), P. 11306 - 11306

Published: Oct. 20, 2021

Cancer is a condition caused by many mechanisms (genetic, immune, oxidation, and inflammatory). Anticancer therapy aims to destroy or stop the growth of cancer cells. Resistance treatment theleading cause inefficiency current standard therapies. Targeted therapies are most effective due low number side effects resistance. Among small molecule natural compounds, flavonoids particular interest for theidentification new anticancer agents. Chalcones precursors all have biological activities. The activity chalcones ability these compounds act on targets. Natural chalcones, such as licochalcones, xanthohumol (XN), panduretin (PA), loncocarpine, been extensively studied modulated. Modification basic structure in order obtain with superior cytotoxic properties has performed modulating aromatic residues, replacing residues heterocycles, obtaining hybrid molecules. A huge chalcone derivatives diaryl ether, sulfonamide, amine obtained, their presence being favorable activity. amino group aminochalconesis always antitumor This why molecules different nitrogen hetercycles obtained. From these, azoles (imidazole, oxazoles, tetrazoles, thiazoles, 1,2,3-triazoles, 1,2,4-triazoles) importance identification

Language: Английский

Citations

121

Translational control of stem cell function DOI
James A. Saba, Kifayathullah Liakath‐Ali, Rachel Green

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2021, Volume and Issue: 22(10), P. 671 - 690

Published: July 16, 2021

Language: Английский

Citations

120